A comparison of insomnia and depression as predictors of disability pension: the HUNT Study

Simon Overland, Nicholas Glozier, Børge Sivertsen, Robert Stewart, Dag Neckelmann, Steinar Krokstad, Amnstein Mykletun, Simon Overland, Nicholas Glozier, Børge Sivertsen, Robert Stewart, Dag Neckelmann, Steinar Krokstad, Amnstein Mykletun

Abstract

Study objectives: Depression and insomnia are common and frequently comorbid. Unlike the priority now accorded to depression, insomnia is comparatively ignored as a reason for impaired occupational functioning. The objective of this study was to compare their relative impact upon medically certified disability pension award.

Design: Historical cohort study

Setting: Data from a population-based health survey in Nord-Trøndelag County in Norway (HUNT-2) was linked with a comprehensive national social security database.

Participants: Participants within working age (20-66 years of age) not claiming disability pension (N = 37,302).

Interventions: N/A.

Measurements and results: We compared complaints of insomnia and depression as predictors of disability pension award 18-48 months after a health survey. Insomnia complaints and depression each were similarly associated with disability pension award after adjustment for multiple health and sociodemographic factors, with similar odds ratios (1.66 [1.37-2.01] and 1.56 [1.24-1.96] respectively). Comorbidity did not contribute to disability beyond that expected from each condition. Taking the higher prevalence of insomnia complaints into account, insomnia complaints contributed as much or even more than depression to work-related disability.

Conclusions: Depression is regarded as a major contributor to work disability and is increasingly the primary diagnosis in disability pension award. Our results suggest that although rarely reported in official registries of disability pension causes, insomnia has an equally important and independent role, particularly among the younger group. This suggests that this potentially treatable factor has considerable economic impact and should receive more attention in clinical and public health management.

References

    1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.
    1. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatric Res. 1997;31:333–46.
    1. NIH. State-of-the-art conference statement on manifestations and management of chronic insomnia in adults. 2005 Jun 13-15. Report No. 22 (2)
    1. APA . Diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Association; 1987.
    1. Stepanski EJ, Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia. Sleep Med Rev. 2006;10:7–18.
    1. Lichstein KL. Secondary insomnia: a myth dismissed. Sleep Med Rev. 2006;10:3–5.
    1. Bixler E, Vgontzas A, Lin H, Vela-Bueno A, Kales A. Insomnia in central Pennsylvania. J Psychosom Res. 2002;53:589–92.
    1. Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality-of-life in primary-care patients with mental-disorders - results from the PRIME-MD 1000 Study. JAMA. 1995;274:1511–7.
    1. Leger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep. 2002;25:625–9.
    1. Stoller MK. Economic effects of insomnia. Clin Ther. 1994;16:873–97.
    1. Stewart W. Cost of lost productive work time among US workers with depression. JAMA. 2003;289:3135–44.
    1. OECD. Policies to promote work and income security for disabled people. Paris: OECD Publications Service; 2003. Transforming disability into ability.
    1. Hensing G, Wahlstrom R. Swedish Council on Technology Assessment in Health Care (SBU). Chapter 7. Sickness absence and psychiatric disorders. Scand J Public Health Suppl. 2004;32:152–80.
    1. Mykletun A, Overland S, Dahl AA, et al. A population-based cohort study of the effect of common mental disorders on disability pension awards. Am J Psychiatry. 2006;163:1412–8.
    1. Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol. 2006;163:1018–24.
    1. Schnorpfeil P, Noll A, Wirtz P, et al. Assessment of exhaustion and related risk factors in employees in the manufacturing industry--a cross-sectional study. Int Arch Occup Environ Health. 2002;75:535–40.
    1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77.
    1. Krokstad S, Westin S. Health inequalities by socioeconomic status among men in the Nord-Trondelag Health Study, Norway. Scand J Public Health. 2002;30:113–24.
    1. Cohen J, Cohen P, West SG, Aiken LS. Applied multiple regression/correlation analysis for the behavioral sciences. 3rd ed. Mahwah, NJ: Lawrence Erlbaum Associates; 2003.
    1. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol. 1988;128:1185–97.
    1. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88:15–9.
    1. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99:325–32.
    1. Greenland S. Re: Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol. 1999;149:884.
    1. Austin PC, Hux JE. A brief note on overlapping confidence intervals. J Vasc Surg. 2002;36:194–5.
    1. Olsson I, Mykletun A, Dahl AA. The hospital anxiety and depression rating scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5 doi: .
    1. Ohayon MM. Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med. 2005;165:35–41.
    1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111.
    1. Ohayon MM, Caulet M, Priest RG, Guilleminault C. DSM-IV and ICSD-90 insomnia symptoms and sleep dissatisfaction. Br J Psychiatry. 1997;171:382–8.
    1. Layard R. The case for psychological treatment centres. BMJ. 2006;332:1030–2.
    1. Roth T, Roehrs T, Pies R. Insomnia: pathophysiology and implications for treatment. Sleep Med Rev. 2007;11:71–9.
    1. Walsh JK. Insights into the public health burden of insomnia. Sleep. 2006;29:142–3.
    1. Morawetz D. Insomnia and depression: which comes first? Sleep Research Online. 2003;5:77–81.
    1. Manber R, Edinger J, Gress J, San Pedro-Salcedo M, Kou T, Kalista T. Cognitive behavioural therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. in press.
    1. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults - A randomized controlled trial. JAMA. 2006;295:2851–8.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe